Chargement en cours...
Modification of left ventricular hypertrophy by chronic etomoxir treatment
1. Etomoxir (2[6(4-chlorophenoxy)hexyl]oxirane-2-carboxylate), an irreversible carnitine palmitoyltransferase 1 inhibitor, reduces the expression of the myocardial foetal gene programme and the functional deterioration during heart adaption to a pressure-overload. Etomoxir may, however, also improve...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1999
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1565820/ https://ncbi.nlm.nih.gov/pubmed/10077244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0702312 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|